TuHURA Biosciences, Inc./NV SEC filings HURA
TuHURA Biosciences, Inc./NV has 928 filings in SEC EDGAR's recent list, going back to Aug 17, 2010. Its latest annual report, Form ARS, was filed on Jul 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (new debt). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Jul 9, 2026 | Dec 31, 2025 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | May 23, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Oct 7, 2024 | Jun 30, 2024 |
| ARS | Annual report to shareholders | May 17, 2024 | Jun 30, 2023 |
| 10-K | Annual report | Sep 18, 2023 | Jun 30, 2023 |
| ARS | Annual report to shareholders | Mar 31, 2023 | Jun 30, 2022 |
| 10-K | Annual report | Sep 27, 2022 | Jun 30, 2022 |
| 10-K | Annual report | Sep 28, 2021 | Jun 30, 2021 |
| 10-K | Annual report | Sep 18, 2020 | Jun 30, 2020 |
| 10-K | Annual report | Sep 9, 2019 | Jun 30, 2019 |
| 10-K | Annual report | Sep 24, 2018 | Jun 30, 2018 |
| 10-K | Annual report | Sep 27, 2017 | Jun 30, 2017 |
| 10-K | Annual report | Sep 13, 2016 | Jun 30, 2016 |
| 10-K/A | Amended annual report | Nov 16, 2015 | Jun 30, 2015 |
| 10-K | Annual report | Sep 3, 2015 | Jun 30, 2015 |
| 10-KT | Transition report | Aug 28, 2014 | Jun 30, 2014 |
| 10-K | Annual report | Mar 10, 2014 | Dec 31, 2013 |
| 10-K/A | Amended annual report | Dec 20, 2012 | Jun 30, 2012 |
| 10-K | Annual report | Oct 15, 2012 | Jun 30, 2012 |
| 10-K | Annual report | Sep 28, 2011 | Jun 30, 2011 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Tampa, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1498382
- Former names
- Kintara Therapeutics, Inc. (until Oct 22, 2024); DelMar Pharmaceuticals, Inc. (until Aug 18, 2020); Berry Only Inc. (until Jan 18, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.